Category Archives: Product Recalls

tattoo, tattoo artist

PRE-TAT Cream is Being Recalled Due to Risk of Infection

Ridge Properties, LLC, issued a recall of 4% lidocaine topical cream & liquid gel products like PRE-TAT and SUPERIOR Pain and Itch Relief, sold at the consumer level.

The products are being recalled due to Microbiological Contamination and Superpotency.

These products are used as a topical anesthetic and are packaged in black jars or bottles with metallic red or green lettering.

Products were distributed nationwide through online sales at the following websites: amazon.com, ebay.com, walmart.com, tatbalm.net, & naturallyhl.com.

The products being recalled include:

PRE-TAT– a numbing agent/topical anesthetic used before applying the tattoo.

The risk from using a contaminated product on skin before a tattoo are greater than normal since the skin is traumatized right after application.

Also, the tattooing process itself can have infectious complications. Introducing more microbiological contamination really increases the risk for getting those complications along with the tattoo.

Soothing Sore Relief Cream– marketed for soothing pain and/or itching associated with hemorrhoids and bedsores.

Superior Pain and Itch Relief– marketed as a numbing agent and topical anesthetic.

The potency of lidocaine in these products is higher than the amount written on the label.

The problem with using a greater potency of lidocaine is the increased risk of methemoglobinemia, a blood disorder that involves the production of abnormal amounts of methemoglobin.

The FDA website has a full list of the recalled products, with their lot numbers and expiration dates.

To date, the company has not received any reports of adverse events related to this recall.
No products from the contaminated lots are currently for sale, or in stock at company or any of its distributors.

The company is notifying its customers by press release and recall letter, and is arranging for replacement of all recalled products.

If you have one of the products with the specified lot number, stop using the product and discard it.

You can also return the product and use the recall response form to reach out to the company for a replacement. Email the form to prncustomercare@gmail.com, or use snail mail to send it to the following address:

Pain Relief Naturally Recall Department
4995 Ridge Dr NE
Salem, OR, 97301

Forms will be sent to you if you have bought this product recently.

If you have questions regarding this recall, contact the company by phone at 877-906-4806, 9 am – 5 pm Monday-Friday, pacific time, or by email at prncustomercare@gmail.com.

If you used the recalled product, and have experienced problems, talk to your healthcare provider. Adverse reactions or quality problems experienced with the use of this product can also be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Complete and submit the report Online
  • Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

_____________

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management brings great benefit to the healthcare industry and the general public alike. We publish this blog to to spread useful and practical information to help people stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to speak!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services 

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store 

Home Generated Medical Waste Drop-Off Points In California

 

drug recall perplexed

This Product Has Been Recalled 75 Times

On May 6, 2019, Vivimed Life Sciences put out another recall for losartan.

The American Health Packaging recall of valsartan on March 7, 2019, the 75th recall of blood pressure medication since the initial contamination occurred.

The problem with the contamination of blood pressure medication has gotten so widespread that the FDA authorized a new generic of valsartan to help relieve shortages when lots after lots of the existing medication were recalled.

Also, the agency compiled a list of 40 blood pressure medications that seem free of contamination. You can find that list here.

Which blood pressure drugs have been recalled?

The common prescription drugs for blood pressure that have been recalled so far include valsartan, losartan, and irbesartan in different combinations and from different manufacturers.

Why have the drugs been recalled?

In each case, a recalled drug was contaminated with N-nitrosodimethylamine (NDMA), N-nitrosodiethylamine (NDEA) or N-Nitroso N-Methyl 4-amino butyric acid (NMBA).

Those chemicals are believed to cause cancer in humans. Research also suggests NDEA can cause liver and blood cell damage.

NDEA is a byproduct of industrial processes, and the FDA is working on identifying how it has been getting into the medication. It can also be created by other chemical reactions. It is found in very low levels in some food and in drinking water, and is used to make rocket fuel.

Can you get cancer from the contaminated drugs?

The FDA says the risk is very low. They estimate that if 8,000 people took the highest valsartan dose, which is 320 milligrams, from recalled batches every day for 4 years, there would likely only be one additional case of cancer over the life of those 8,000 people.

What should you do if you have a perscription for one of the recalled drugs?

Don’t stop taking the medication. The threat from the contamination in the drug is a lesser threat than the consequences of stopping the use of the medication.

However, do contact your pharmacist or Doctor as soon as possible.

They can help you find an alternative.

Because so much of the blood pressure drugs have been recalled, this may be a little more difficult than usual. Also, keep in mind that drugs that are not on the list of recalls are more in demand and therefore the price may have gotten higher.

WebMD has an article up that summarizes the rash of blood pressure medication recalls. You can read the full report here.

_____

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management brings great benefit to the healthcare industry and the general public alike. We publish this blog to to spread useful and practical information to help people stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to speak!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services 

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store 

Home Generated Medical Waste Drop-Off Points In California

 

what is in my meds?

ANOTHER Recall?? More Blood Pressure Meds Taken Off The Market.

“Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25mg, 50mg, And 100mg Due to The Detection of Trace Amounts Of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA) Impurity Found in The Active Pharmaceutical Ingredient (API)”.

We have been following recall notices about blood pressure drugs valsartan and losartan. 

This latest recall follows several others announced since July, when the FDA announced the recall of five separate valsartan blood pressure drugs over possible NDEA and NDMA contamination.

Many more were announced in August as the recall spread to Canada and the European Union. And earlier this month, a blood pressure drug known as irbesartan was recalled as well.

So far, recall notices have been issued for multiple lots, with multiple updates, by multiple generic drug manufacturers. Some of the manufacturers who issued recalls in the past several months include:

Teva, Legacy, Torrent, Sandov, Macleods,  Aurobindo Pharma USA,   Mylan’s.

This is by far the longest-running, ongoing spread of recalls we’ve noticed in the past three years.

What is going on?

Turns out that we weren’t the only curious ones. Bloomberg.com spent a year investigating the FDA’s regulations of the generic drug industry and found a drop-off in inspections and the softening of penalties when problems are identified. Data integrity is compromised as well. FDA inspections at factories from West Virginia to China give cause to doubt the data meant to prove the safety and efficacy of drugs.

Bloomberg’s has done a lot of research on generic drugs and the FDA’s quality control. One of their conclusion was that due to the data integrity problems, even the drugs that are not being recalled may not be as effective or safe as they are meant to be.

Safety and efficacy concerns are not limited to drugs using active ingredients from India and China, but also to drugs manufactured in the States.

Bloomberg has a host of articles around the subject of generic drugs and where we are headed, and they are not encouraging.

One of the reasons for the increased laxity in regulations may be the generic drug initiative run by Scott Gottlieb, FDA Commissioner.

Scott Gottlieb was the FDA Commissioner since May 2017, and spearheaded several important initiatives. Among these are finding solutions to the opioid crises, food safety modernization, an initiative to minimize youth nicotine, youth vaping, and general nicotine addiction.

Another top priority for Gottlieb was getting more generic drugs into the market. The extra competition would drive down prices. This has drawn praise from both parties in Congress and, as an aside, is one of the issues President Trump said he would take care of if he was voted President. Everybody was happy.

In the effort to fast-track generic drug manufacture, some approvals for generic drugs may have come at the expense of quality assurance and oversight to ensure the efficacy and safety of the drugs.

On March 5, 2019, FDA Commissioner Scott Gottlieb announced that he was resigning from his post as FDA Commissioner. He will be leaving in April. Will the FDA tighten regulations after he leaves? We can’t be sure.

They will definitely keep working on keeping more drugs accessible to more people- and on the other initiatives Gottlieb spearheaded during his reign as the FDA Commissioner.

Perhaps, now that Gottlieb put a system in place, they will spend more time fixing the bugs in the system and plugging the holes that allow ineffective and unsafe drugs to hit the market. Maybe we will all notice that our medication is working better all of a sudden, and spend less time visiting Doctors to try different versions of what is supposed to be the same basic drug. Maybe the drug prices will go up again. Who knows?

In the meantime, keep checking for updates on drug recalls on our website, or go directly to the FDA’s website.

Above all, Be Safe.

______________

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management brings great benefit to the healthcare industry and the general public alike. We publish this blog to to spread useful and practical information to help people stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to speak!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services 

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store 

Home Generated Medical Waste Drop-Off Points In California

 

infant swallowing medicine

Ibuprofen for Infants Is Being Recalled by Tris Pharma, Inc.

Three lots of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, are being recalled by Tris Pharma.

These lots had potentially higher concentrations of ibuprofen in the bottles. 

It is possible that infants, who are more susceptible to slight variations in potency, may suffer adverse side effects if the medication is a higher concentration than listed.

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID), used commonly for pain relief. It works by blocking your body’s production of substances that cause inflammation. This effect helps to decrease swelling, pain, or fever.

Possible side effects from an incorrect dose of ibuprofen may include permanent NSAID-associated renal injury.

Infants taking ibuprofen can suffer serious bleeding as a side effect- usually gastrointestinal bleeding, commonly in the stomach but possibly anywhere along the gastrointestinal tract. Bloody vomit, a stomachache that doesn’t go away, and feeling faint are indicators of stomach bleeding.

Other possible side effects are liver problems like jaundice and hepatitis. As many as 15 percent of infants taking ibuprofen showed elevated liver function.

When giving a child ibuprofen, keep an eye out for nausea, vomiting, epigastric pain,and, more rarely, diarrhea.

Tris Pharma, Inc., sold the affected lots to only one customer, who distributed the ibuprofen to Family Wellness, CVS, and Equate, among others. Tris Pharma, Inc. has urgently notified this customer and is arranging the return of all affected products.

To date, Tris Pharma, Inc. hasn’t received any reports of adverse side effects related to the lots they are recalling.

The affected lots are listed on the FDA website.

Tris Pharma is a fully integrated pharmaceutical company focused on the development of innovative medicines that address unmet patient needs. Using its proprietary technology platform, LiquiXR®, Tris has pioneered the delivery of sustained release in the liquid, chewable, orally disintegrating tablet, and other dosage forms that benefits a wide variety of patients and their unique needs. Tris’ Nobuse™ technology provides abuse deterrence for opioids and other abuse-prone drugs. Tris’ research, manufacturing and commercial facilities are located in Central New Jersey. For more information, please visit their website. .

Consumers with questions regarding this ibuprofen recall can contact Tris Customer Service at 732-940-0358 (Monday through Friday, 8:00am ET- 5:00pm PT) or via email at Customer Service Email .

Adverse reactions or quality problems associated with the use of this product should be reported to a physician or hospital. After that, they should be reported to FDA’s MedWatch Adverse Event Reporting program either by phone, on line, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

You can now follow the FDA on Facebook and Twitter. Get immediate, up-to-date notices about product recalls and other important notifications.

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management brings great benefit to the healthcare industry and the general public alike. We publish this blog to to spread useful and practical information to help people stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to speak!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services 

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store 

Home Generated Medical Waste Drop-Off Points In California

 

 

 

 

 

eye dropper close to eye

Puriton Eye Relief Drops Can Harm Your Eyes.

Kadesh Incorporation Issued a Voluntary Nationwide Recall of Puriton Eye Relief Drops. The complete statement can be found on the FDA’s recall page.

The recall was due to non-sterile conditions during production.

When the FDA inspected the production site, the investigators discovered that the necessary production controls and conditions for sterility were not being observed.

Opthalmic drugs are required to be sterile in particular, because using a non-sterile eye drop can potentially threaten the vision of the consumer due to the risk of an eye infection. Also, the pH factor of the eye drops can cause direct destruction of tissues in the anterior chamber, cornea, and even deeper in the eye.

This can potentially cause scarring, vision loss, or glaucoma.

To date, there have been no reports of adverse effects related to the Puriton Eye Relief Drops.

Purtion Eye Relief Drops is an over-the-counter homeopathic eye drop product. Its uses include temporary relief of burning and irritation of the eye due to dryness and temporary relied of discomfort due to minor irritations to the eye, like wind and sun exposure. Other uses were the relief of redness, watery eyes, inflamed eyes, itching, burning, tearing eyes, eye pain, and lubricant.

Kadesh, Inc. of Garden Grove, CA is voluntarily recalling all lots of Puriton EyeRelief Drops , 0.5 oz. (15ml) bottle, UPC 7 36972 1679 0, to the consumer level.

It is packaged in a 15 ml plastic bottle, and was distributed nationwide through the company’s online stores and the retail distributors they work with. All distributors and customers are being notified by letter and Kadesh is arranging for the return of all the recalled products.

As of now, the product cannot be found anywhere online, neither on the Puriton website nor online markets like Amazon.

Anyone who has recalled eye drops should stop usage or sale of the product.

Consumers with questions regarding this recall can contact the Recall Department at contact@puriton.us, available Monday through Friday, from 9 am to 6 pm (Pacific Time).

Product may be returned to Kadesh Inc. by mail:

4731 Lincoln Way, Garden Grove, CA 92841.

Anyone who experienced any problems that may be related to the use of the non-sterile product should contact their healthcare provider.

Adverse reactions or quality problems associated with the use of this product may be reported to FDA’s MedWatch Adverse Event Reporting program either by phone, on line, by regular mail or by fax.

______

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management brings great benefit to the healthcare industry and the general public alike. We publish this blog to to spread useful and practical information to help people stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to speak!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services 

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store 

Home Generated Medical Waste Drop-Off Points In California

 

dangerously high blood pressure

Losartan: Another Blood Pressure Medication Is Being Recalled

The FDA is recalling Irbesartan and Losartan, more angiotensin II receptor blockers (ARBs), after discovering traces of NDEA in them.

This new recall is for Losartan sold by Sandoz.

The recall is only for the 100mg/25mg tablets and does not involve other versions of the losartan drug.

This recall impacts less then 1% for the total losartan drug products in the US market. However, it is only the tip of the iceberg for pharmaceutical products  from the same manufacturer found tainted with amounts NDMA and NDEA that are not safe by the FDA’s standards.

The active ingredient in the recalled lot of losartan tested positive for NDEA.

NDEA is a suspected human and animal carcinogen. It was found within an ingredient that was made and supplied by the Zhejiang Huahai Pharmaceutical Company Co. Ltd. This same company supplied the tainted active ingredient used in the recalled lots of valsartan.

After the European Medicines Agency, (EMA), and then the FDA, confirmed the presence of NDMA and NDEA impurities in Valsartan, the FDA launched an investigation, including an inspection of the Zhejiang Huahai facility. They found traces of both NDEA and NDMA.

At the end of September, the FDA placed the Chinese company on an import alert, which means that any  active pharmaceutical products or finished products from the company would not enter the United States.

Valsartan is used in blood pressure medication and some vaccine products, among others.

The FDA is testing all ARBs- for NDEA and NDMA impurities and is keeping an ongoing list of recalled medicines and those that are not going to need to be recalled.

In August, 2018, FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research, released a statement on the FDA’s ongoing investigation into valsartan impurities and recalls.

They described what caused the impurity in the drugs, what the FDA is doing about it, and the risk assessment for patients who have been taking the tainted drug.

The scientists working for the FDA estimated that,  “if 8,000 people took the highest valsartan dose (320 mg) from NDMA-affected medicines daily for four years, (this is the amount of time they estimated the affected drugs were being marketed), there may be one additional case of cancer over the lifetimes of these 8,000 people beyond the average cancer rate among Americans.”

That estimate was based on the highest daily dose, however many people may have taken lower doses, and therefore their risks would be less.

FDA expects the actual cancer risk to most consumers to be lower than the estimate.

The losartan recall is for lot number JB8912. If you are taking losartan, you can check the lot number on the bottle and see if the numbers match.

If your drug is on the recall list, the FDA suggests that you continue to take it until you can get a replacement from a Doctor or Pharmacist.

Questions regarding this recall can be directed to Sandoz Inc. at 1-800-525-8747 Monday-Friday 8:30 AM – 5:00 PM (EST) or email usdrugsafety.operations@novartis.com.

_________

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management brings great benefit to the healthcare industry and the general public alike. We publish this blog to to spread useful and practical information to help people stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to speak!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services 

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store 

Home Generated Medical Waste Drop-Off Points In California

woman with pill

Drug Recall: ORTHO-NOVUM

Janssen Pharmaceuticals has issued a voluntary recall for three lots of ORTHO-NOVUM tablets. The packages had the wrong instructions for the Veridate® dispenser included in them.

Only three lots of ORTHO-NOVUM were affected: ORTHO-NOVUM® 1/35, ORTHO-NOVUM® 7/7/7, ORTHO-NOVUM® 7/7/7. The FDA website has detailed information about the specific lots.

ORTHO-NOVUM® (norethindrone/ethinyl estradiol) is a contraceptive. It is used as birth control, to prevent pregnancy, and at times used as hormonal treatment for severe acne.

ORTHO-NOVUM® pill packs contain 28 pills with active medication. 21 have active medication/hormones, and 7 pills are inert reminder pills.

The potential risk of taking ORTHO-NOVUM® without the appropriate instructions for correct use of the Veridate® dispenser pack is that the pills would be taken in the incorrect order.

That could be harmless and still provide an adequate dose. However, the other risk is that the inactive “reminder” pill would be taken on days that the active pill is necessary. This could lead to breakthrough bleeding and, in a case of active ovulation, could lead to unintended pregnancy.

The lots with the inaccurate patient instructions were distributed only in the United States, to wholesalers, distributors, and pharmacies. Janssen Pharmaceuticals have already sent out letters and notifications to return the affected products.

Consumers with ORTHO-NOVUM® product from the affected lots can get the correct instructions for the Veridate® dispenser pack at https://www.janssen.com/us/our-products. If they have any concerns about their treatment program, they can talk to their prescribing medical professional. Consumers should not stop taking the product and if they do miss a dose, they should follow the instructions included in the packet for missing a dose.

The ORTHO-NOVUM® product itself remains safe and will be effective with the appropriate dispenser instructions. 

No other ORTHO® contraceptive products beyond those three lots are impacted by this recall action.

Any questions regarding this recall can be addressed to Janssen Pharmaceuticals by phone: 1-800-526-7736 (1-800-JANSSEN) Monday through Friday from 9:00 am to 8:00 pm ET. Consumers should contact their healthcare provider if they have experienced any problems that might be related to using this product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

________

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management brings great benefit to the healthcare industry and the general public alike. We publish this blog to to spread useful and practical information to help people stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to speak!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services 

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store 

Home Generated Medical Waste Drop-Off Points In California

 

food poisoning, listeria

Product Recall: Fried Onions with Listeria and Salmonella

Possible Salmonella and Listeria Monocytogenes contamination is affecting multiple products and crossing State lines.

The reason for the recall was contaminated ingredients sold and shipped by McCain Foods. Initially, they identified the contamination in their onion ingredients.

First, “Out of an abundance of caution”,  Hy-Vee recalled the following products from all of its stores:

Hy-Vee Bacon Wrapped Cowgirl Chicken Grillers, Hy-Vee Fire Roasted Tomato, Spinach, Mozzarella Twice Baked PotatoHy-Vee Cowgirl Chicken Griller PattyHy-Vee Gourmet Steakhouse Mushroom & Swiss BurgerHy-Vee Ground Beef Sliders Mushroom & Swiss

The impacted products had a “Best If Used By” date of Oct. 22, 2018, or sooner

The instructions for customers who bought any of the recalled products was to avoid consuming them, throw them out, or return them to the local Hy-Vee store for a refund.

Questions about Hy-Vee recalled products will be addressed 24 hours a day with Hy-Vee Customer Care representatives at 1-800-772-4098.

The FDA has a full list of the Hy-Vee recalled products on their site.

Since then, the recall has spread to a dozen U.S. food manufacturers including Bakkavor Foods, Envolve Foods and Ruiz Food Products. The food makers notified the U.S. Department of Agriculture about products they shipped that could include ingredients such as corn, diced onions and other vegetables possibly tainted with bacteria – all provided from McCain Foods.

McCain Foods, which has headquarters in Canada and offices in Illinois, said they identified a potential health risk related to their fire roasted, caramelized, or sauteed frozen vegetable and fruit products that were produced at their Colton (California) facility.

Included in the recall:

Salads, wraps, burritos and pizza sold at Harris Teeter, Kroger, Whole Foods, 7-Eleven, Ralphs, Trader Joe’s, Walmart, Simple Truth, and other major retailers.

The Fresh Market said they removed some pizza and pasta salad products and self-serve portions from the shelves of 161 stores in 22 states.

For a complete list of affected products, check the USDA’s current recalls site.

According to McCain Foods and the USDA, there have been no confirmed reports of adverse reactions due to consumption of any of the recalled products as of now.

Listeriosis is a food-borne infection caused by Listeria bacteria that is commonly found in water, soil, and feces. Humans are infected when they consume foods that harbor the bacteria.

The most common foods to cause listeriosis outbreaks are deli meats and unpasteurized dairy products. However, many other foods have also been found to spark outbreaks, including caramel apples, cantaloupe, and cabbages fertilized by sheep manure.

Adults who are healthy and have strong immune systems are less at risk of listeriosis. Pregnant women are more susceptible to infection and can pass the infection to the fetus or suffer complications or miscarriage. Other people who have an increased risk of Listeria infection are the elderly, children or people who are immuno-compromised.

Severe Listeria infections can cause gastroenteritis (“stomach flu”), bacteremia, sepsis, meningitis, pneumonia, osteomyelitis and endocarditis.

An estimated 1,600 people get Listeriosis each year in the U.S., and about 260 die from it, according to the CDC. 

Listeria and Salmonella infections usually resolve on their own without treatment. The best defense is prevention. Heat all foods that may be harboring bacteria.

There are also natural remedies that assist with the symptoms and with overcoming the infection that have been proven useful.

With proper rest, care and in the worst case, with treatment, This Too Shall Pass.

______

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management brings great benefit to the healthcare industry and the general public alike. We publish this blog to to spread useful and practical information to help people stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to speak!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services 

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store 

Home Generated Medical Waste Drop-Off Points In California

 

valsartan pill bottle

Drug Recall: Valsartan

The U.S. Food and Drug Administration has twice expanded its recall of several drug products containing the active ingredient Valsartan from Major Pharmaceuticals, Solco Healthcare, and Teva Pharmaceuticals Industries Ltd., as well as valsartan/hydrochlorothiazide from Solco and Teva.

The reason for the recall is the presence of N-nitrosodimethylamine (NDMA).

NDMA was found in the batches that contained the valsartan ingredient manufactured by  Zhejiang Huahai Pharmaceuticals, Linhai, China.

NDMA is classified as a probable human carcinogen.

The presence of NDMA was unexpected, said the FDA, and is possibly related to changes in how the active substance was manufactured.  According to the EPA, NDMA — which was formerly used in rocket fuel, among other things — can be an unintended byproduct of wastewater treatment plants that use chemical compounds called chloramines for disinfection.

Zhejiang Huahai has stopped distributing its valsartan API and the FDA is working with the affected companies to reduce or eliminate the valsartan API impurity from future products. 

The FDA’s review is ongoing and has included investigating the levels of NDMA in the recalled products, assessing the possible effect on patients who have been taking them and what measures can be taken to reduce or eliminate the impurity from future batches produced by the company.

The FDA will continue to investigate this issue and provide additional information when it becomes available.

The agency encourages patients and health care professionals to report any adverse reaction to the FDA’s MedWatch program.

You can see a list of the recalled medications, as well as a list of products containing valsartan that have not been recalled, on the FDA’s website. Only products contaminated with NDMA are being recalled — not all valsartan tablets.

Not all valsartan products contain NDMA.

Valsartan is used for the treatment of hypertension (high blood pressure) and for the treatment of heart failure. It is also indicated as a treatment for left ventricular failure and left ventricular dysfunction following myocardial infarction. In combination with hydrochlorothiazide, it is used in the treatment of hypertension.

If you are taking valsartan, you should continue taking the medicine until you can determine if you need a replacement product. You can do this by checking the list of affected companies and batches on the FDA’s website.

The risk of stopping treatment can be more harmful to your health than taking the contaminated valsartan for just a bit longer, until you can get it replaced.

Contact your Doctor or Pharmacist. You may get a prescription for a different medication that treats the same indications, or a refill of valsartan medication from a batch that was not affected by the recall.

CBS News has a segment playing on the valsartan recall.

Customers and patients with Medical-related Questions, information about an Adverse Event or other questions about the Teva product’s being recalled should contact Teva’s Medical Information by phone at: 888-838-2872, option 3, option 4, then option 1.

  • Live calls are received Monday-Friday, 9:00AM-5:00PM Eastern Time with Voicemail available 24 hours/day, 7 days/week or email druginfo@tevapharm.com.

Adverse reactions or quality problems experienced with the use of this product may be reported to Teva directly at 888- 838-2872 or to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

_______

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management brings great benefit to the healthcare industry and the general public alike. We publish this blog to to spread useful and practical information to help people stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to speak!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services 

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store 

Home Generated Medical Waste Drop-Off Points In California

child on sand

Cortaid Recall: Anti-Itch Application May End Up Needing Antibiotic

Product Quest has issued a Cortaid recall, among other products. An internal quality review revealed possible contamination of Cortaid Anti-itch Cream products with  Pseudomonas aeruginosa.

The recall covers all lots and expiration dates of Cortaid Creams.

This includes Cortaid 12-hour Advanced Anti-Itch Cream, sold in 1.5-ounce tubes; Cortaid Maximum Strength Cream, sold in 1-ounce tubes; and Cortaid Intensive Therapy Cooling Spray (2-ounces). Anyone with these products should return them to the store for a full refund.

Pseudomonas aeruginosa is a common bacteria that can cause pseudomonas infection. Most pseudomonas infections occur in hospitalized patients and/or with compromised or weakened immune systems. An estimated 51,000 healthcare-associated P. aeruginosa infections occur in the United States each year. More than 6,000 (13%) of these are multidrug-resistant, with roughly 400 deaths per year attributed to these infections. 

Multidrug-resistant Pseudomonas was given a threat level of serious threat in the CDC AR Threat report.

Healthy people can also develop mild illness with Pseudomonas aeruginosa, especially when exposed through water. Ear infections are a common reaction, especially in children. Exposure to the bacterial through inadequately chlorinated hot tubs or swimming pools can result in generalized skin rashes as well. Patients using infected extended-wear contact lenses have reported eye infections.

To the best of Product Quest’s knowledge, the company has not received any reports of adverse events related to this recall so far.

Cortaid is not the only product that Product Quest is recalling for  Pseudomonas aeruginosa contamination. All its nasal products and baby oral gels are suspect to the bacteria and are being recalled. In August, Product Quest Manufacturing recalled nasal sprays sold as name brands and as the house brands for Walgreens, CVS, Meijer, Dollar General, Rexall, Family Dollar, Rite-Aid and Harmon.

On September 17, Valeant Pharmaceuticals announced the recall of all Cortaid creams, and on September 24, they recalled Ocean Saline Nasal Spray.

MediNatura recalled 19 lots of two nasal sprays, a throat spray and a cough syrup for a “possible microbial contamination” in the water-based products. Clearlife Nasal Spray, Reboost Nasal Spray, Reboost Throat Spray, each in 20 ml bottles, and 125 ml bottles of Reboost Cough Syrup are involved in the recall.

“Administration or use of drug products with microbial contamination, could potentially result in increased infections that may require medical intervention,” MediNatura’s website recall notice says.

To date, the company has not received any reports of illness or injury.

KIngBio has recalled Baby Teething Liquids for microbial contamination, and many other water-based products, due to the same bacteria in their water.

Product Quest is notifying its customers by oral and written communication and is arranging for return/replacement etc. of all recalled products. Consumers/distributors/retailers that have product which is being recalled should stop using the product and return it to the place of purchase or discard the product.

Consumers with questions regarding this recall can contact Product Quest Manufacturing LLC at (386) 239-8787, Monday through Friday from 8 am to 4 pm, EST.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

______

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management brings great benefit to the healthcare industry and the general public alike. We publish this blog to to spread useful and practical information to help people stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to speak!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services 

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store 

Home Generated Medical Waste Drop-Off Points In California

hand holding nasal spray

Product Recall: CVS Health 12 Hour Sinus Relief Nasal Mist

CVS Health 12 Hour Sinus Relief Nasal Mist, a clear, colorless liquid in a spray bottle with a nozzle that fits up your nostril, is having problems with lot number 173089J. There was microbiological contamination in that lot. The microbe contamination was identified as Pseudomonas aeruginosa.

Holly Hill, FL, Product Quest Manufacturing (“Product Quest”) is voluntarily recalling Lot# 173089J of CVS Health 12 Hour Sinus Relief Nasal Mist, a clear, colorless liquid to the consumer level. 16,896 units were released with UPC code 50428432365. The affected CVS Health 12 Hour Sinus Relief Nasal Mist lot is Lot # 173089J, EXP 09/19.

The product can be identified by a white nasal spray bottle and an orange label with Sinus Relief stated in white with CVS Health on top left.

The box has the same colors and words on it. On the side panel of the carton, the affected lot would have the words: “Lot 173089J” and “EXP 09/19” coded on it.

The nasal decongestant is packaged in 0.5 fluid ounce bottles, in individual folding carton.

Product was distributed Nationwide to retail outlets.

 Repetitive use of a nasal spray containing a gram-negative pathogen can potentially lead to colonization and subsequent infection which can be life threatening.

Infection is usually benign, but in certain patient populations, such as those with cystic fibrosis or  immuno-compromised.

The company has not received any reports of adverse events related to this recall.

So far, anyways.

Product Quest is notifying its customers by oral and written communication and is arranging for return/replacement etc. of all recalled products.

Consumers/distributors/retailers that have product which is being recalled should stop using the product and return it to the place of purchase or discard the product.

Consumers with questions regarding this recall can contact Product Quest Manufacturing LLC at (386) 239-8787, Monday through Friday from 8 am to 4 pm, EST.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Complete and submit the report Onlinefda.gov/medwatch/report.htm
  • Regular Mail or Fax: Download form fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

__________

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management brings great benefit to the healthcare industry and the general public alike. We publish this blog to to spread useful and practical information to help people stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to speak!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services 

MedWaste’s Blog Index

Medical Waste Regulations

Medical Waste Products 

Home Generated Medical Waste Drop-Off Points In California

blood pressure meter

Product Recall: Valsartan

Teva Pharmaceuticals USA today confirmed a voluntary recall to the consumer / user level of 29 lots of single and 51 lots of combination valsartan medicines .

The products subject to recall  are packed in bottles. These lots were distributed Nationwide to Teva’s Direct Accounts (Wholesale/Distributor/Retail/Repackagers/VA Pharmacy, et. al).

These were distributed under the Actavis label in the U.S. They are being recalled due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) that was manufactured by Zhejiang Huahai Pharmaceutical.

Teva is not the only company to recall Valsartan. Major Pharmaceuticals, and Solco Healthcare are also recalling Valsartan/ Hydrochlorothiazide due to the same impurity detected.

The FDA action came after 22 other countries issued recalls involving 2,300 valsartan batches sent to Germany, Norway, Finland, Sweden, Hungary, the Netherlands, Austria, Ireland, Bulgaria, Italy, Spain, Portugal, Belgium, France, Poland, Croatia, Lithuania, Greece, Canada, Bosnia and Herzegovina, Bahrain and Malta.

What Is Valsartan?

Valsartan is used for the treatment of hypertension (high blood pressure) and for the treatment of heart failure. It is also indicated as a treatment for left ventricular failure and left ventricular dysfunction following myocardial infarction. In combination with hydrochlorothiazide, it is used in the treatment of hypertension.

Why Is It Being Recalled?

The impurity detected in the API is N- nitrosodimethylamine (NDMA), which is a substance that occurs naturally in certain foods, drinking water, air pollution,  and industrial processes. It can be used to make liquid rocket fuel, softeners and lubricants, among other products. It can also be unintentionally produced through certain chemical reactions and is a byproduct from some pesticide manufacturing, the making of rubber tires or fish processing.a

N- nitrosodimethylamine (NDMA) has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification.

The toxin affects the liver and causes liver fibrosis or scarring and liver tumors in rats.Exposure to high levels of NDMA may cause liver damage in humans, according to the US Environmental Protection Agency.

To date, TEVA has not received any reports of adverse events related to this recall.

What Should You Do?

Don’t stop taking your blood pressure meds!!

First of all, not all medicines containing valsartan are involved in the recall.

Check the FDA recall site or call your pharmacy to find out if the bottle you have is from a contaminated lot before taking further action.

Valsartan alternatives are available.

Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication. Patients who are on valsartan should continue taking their medication, as the risk of harm to a patient’s health may be higher if the treatment is stopped immediately without any alternative treatment.

Questions, concerns, adverse reactions or quality problems experienced with the use of this product may be reported to Teva directly at 888- 838-2872 or to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

_________

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management brings great benefit to the healthcare industry and the general public alike. We publish this blog to to spread useful and practical information to help people stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to speak!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services 

MedWaste’s Blog Index

Medical Waste Regulations

Medical Waste Products 

Home Generated Medical Waste Drop-Off Points In California